Univ. of Wisconsin-Madison/Jackson Research Group Trials

Univ. of Wisconsin-Madison/Jackson Research Group	Welcome, Profile Billing Logout

Univ. of Wisconsin-Madison/Jackson Research Group

Welcome, Profile Billing Logout

2 Trials

Active Trials Industry lead sponsorIndustry collaborator

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Jackson, Daniel L

PANDA, NCT05347771: Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents

Recruiting

240

Dupilumab, Dupixent, IL4Ra mAb, Placebo, Placebo for Dupilumab

National Institute of Allergy and Infectious Diseases (NIAID), Childhood Asthma in Urban Settings (CAUSE), Regeneron Pharmaceuticals, Rho Federal Systems Division, Inc.

Asthma

08/25

12/25

adored, NCT05003804: Allergic Disease Onset Prevention Study

Active, not recruiting

1/2

264

US, RoW

STMC-103H, Placebo

Siolta Therapeutics, Inc.

Atopic Dermatitis, Type 1 Hypersensitivity

11/24

10/25

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites